Naringenin regulates gut microbiota and SIRT1/ PGC-1ɑ signaling pathway in rats with letrozole-induced polycystic ovary syndrome

To evaluate the effect of naringenin on improving PCOS and explore the mechanism. Firstly, we carried out differential gene expression analysis from transcriptome sequencing data of human oocyte to screen the KEGG pathway, then the PCOS-like rat model was induced by letrozole. They were randomly div...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biomedicine & pharmacotherapy 2022-09, Vol.153, p.113286-113286, Article 113286
Hauptverfasser: Wu, Yan-Xiang, Yang, Xiu-Yan, Han, Bao-Sheng, Hu, Yuan-Yuan, An, Tian, Lv, Bo-Han, Lian, Juan, Wang, Ting-Ye, Bao, Xue-Li, Gao, Lin, Jiang, Guang-Jian
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To evaluate the effect of naringenin on improving PCOS and explore the mechanism. Firstly, we carried out differential gene expression analysis from transcriptome sequencing data of human oocyte to screen the KEGG pathway, then the PCOS-like rat model was induced by letrozole. They were randomly divided into four groups: Normal group (N), PCOS group (P), Diane-35 group (D), and Naringenin group (Nar). The changes of estrus cycle, body weight, ovarian function, serum hormone levels, glucose metabolism, along with the expression of SIRT1, PGC-1ɑ, claudin-1 and occludin of the ovary and colon were investigated. Furthermore, the composition of the gut microbiome of fecal was tested. By searching the KEGG pathway in target genes, we found that at least 15 KEGG pathways are significantly enriched in the ovarian function, such as AMPK signaling pathway, insulin secretion, and ovarian steroidogenesis. Interestingly, naringenin supplementation significantly reduced body weight, ameliorated hormone levels, improved insulin resistance, and mitigated pathological changes in ovarian tissue, up-regulated the expression of PGC-1ɑ, SIRT1, occludin and claudin-1 in colon. In addition, we also found that the abundance of Prevotella and Gemella was down-regulated, while the abundance of Butyricimonas, Lachnospira, Parabacteroides, Butyricicoccus, Streptococcus, Coprococcus was up-regulated. Our data suggest that naringenin exerts a treatment PCOS effect, which may be related to the modulation of the gut microbiota and SIRT1/PGC-1ɑ signaling pathway. Our research may provide a new perspective for the treatment of PCOS and related diseases. The systematic framework. PCOS: polycystic ovary syndrome, N: normal group; P: PCOS group; D: Diane-35 group; Nar: naringenin group. [Display omitted] •Naringenin regulates serum hormone levels and improves insulin resistance•Naringenin contributes to more normal ovarian function and body weight•Naringenin up-regulated the expression of PGC-1ɑ and SIRT1 in ovary•Naringenin increased the expression of occludin and claudin-1 in the colon•Various beneficial microbes in the gut appear to be regulated by naringenin
ISSN:0753-3322
1950-6007
DOI:10.1016/j.biopha.2022.113286